TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
IMCR

Immunocore Holdings Ltd

Healthcare · Biotechnology

30.50$ -3.7% vs. previous close Closing price · As of: Nov 12, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Immunocore Holdings Ltd (IMCR) with date, type and a link to the original document.

Filings IMCR
Date Type Filing Original
11/09/2026 Ownership disclosure Form SC 13G filed with the SEC View document ↗
11/06/2026 Current report (8-K) Immunocore Holdings plc (IMCR): Results of Operations and Financial Condition; Financial Statements and Exhibits View report ↗
09/14/2026 Current report (8-K) Immunocore Holdings plc (IMCR): Regulation FD Disclosure; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?